LOP628

LOP628 · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LOP628, covering 2016-04-05 to 2016-04-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia [Phase 1]